期刊文献+

妊娠期高血压患者24 h尿蛋白定量、CRP、UA水平与妊娠结局及疾病严重程度的相关性研究 被引量:3

下载PDF
导出
摘要 目的分析妊娠期高血压(PIH)患者24 h尿蛋白定量、C反应蛋白(CRP)、尿氮素(UA)水平与妊娠结局及疾病严重程度的相关性。方法选50例PIH、41例轻度子痫前期和30例重度子痫前期患者作为研究对象,选择同期健康者40例作为对照组。比较各组血压、不良妊娠结局、以及24 h尿蛋白定量、CRP、UA水平。结果PIH患者血压和不良妊娠结局发生率均显著高于对照组(均P<0.05),并且随着PIH的病情加重,血压和不良妊娠结局发生率显著升高(P<0.05)。PIH患者24 h尿蛋白定量、CRP、UA水平均高于对照组(P<0.05);且随着病情的加重,24 h尿蛋白定量、CRP、UA水平均升高(均P<0.05)。24 h尿蛋白定量、CRP、UA水平均与病情严重程度存在正相关关系(均P<0.05)。PIH患者中出现不良妊娠结局患者的24 h尿蛋白定量、CRP、UA水平均高于未出现不良妊娠结局的患者(均P<0.05)。患者出现不良妊娠结局的危险因素(均P<0.05)。结论高水平的24 h尿蛋白定量、CRP、UA与PIH患者的病情严重程度呈现正相关关系,且24 h尿蛋白定量、CRP、UA水平是PIH患者出现不良妊娠结局的危险因素。
机构地区 余姚市人民医院
出处 《现代实用医学》 2020年第4期459-460,477,共3页 Modern Practical Medicine
  • 相关文献

参考文献7

二级参考文献58

  • 1Li Wang,Zhi-Qiang Liu,Ying-Qian Huo,Li-Juan Yao,Xue-Gong Wei,Yun-Fang Wang.Change of hs-CRP,sVCAM-1,NT-proBNP levels in patients with pregnancy-induced hypertension after therapy with magnesium sulfate and nifudipine[J].Asian Pacific Journal of Tropical Medicine,2013,6(11):897-901. 被引量:46
  • 2RylanderR. Pre-eclampsia during pregnancy and cardiovascular disease later in life: the case for a risk group[J]. Arch Gynecol Obstet, 2015, 292(3): 519–521. DOI:10.1007/s00404–015–3676–3.
  • 3WilsonBJ, WatsonMS, PrescottGJ, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study[J]. BMJ, 2003, 326(7394): 845. DOI:10.1136/bmj.326.7394.845.
  • 4LinYS, TangCH, YangCY, et al. Effect of pre-eclampsia-eclampsia on major cardiovascular events among peripartum women in Taiwan[J]. Am J Cardiol, 2011, 107(2): 325–330. DOI:10.1016/j.amjcard.2010.08.073.
  • 5GeelhoedJJ, FraserA, TillingK, et al. Preeclampsia and gestational hypertension are associated with childhood blood pressure independently of family adiposity measures: the Avon Longitudinal Study of Parents and Children[J]. Circulation, 2010, 122(12): 1192–1199. DOI:10.1161/CIRCULATIONAHA.110.936674.
  • 6Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy[J]. Obstet Gynecol, 2013, 122(5): 1122–1131. DOI:10.1097/01.AOG.0000437382.03963.88.
  • 7ZoetGA, KosterMP, VelthuisBK, et al. Determinants of future cardiovascular health in women with a history of preeclampsia[J]. Maturitas, 2015, 82(2): 153–161. DOI:10.1016/j.maturitas.2015.07.004.
  • 8SattarN. Do pregnancy complications and CVD share common antecedents[J]. Atheroscler Suppl, 2004, 5(2): 3–7. DOI:10.1016/j.atherosclerosissup.2004.03.002.
  • 9Gaugler-SendenIP, TamsmaJT, van der BentC, et al. Angiogenic factors in women ten years after severe very early onset preeclampsia[J]. PLoS One, 2012, 7(8): e43637. DOI:10.1371/journal.pone.0043637.
  • 10FreemanDJ, McManusF, BrownEA, et al. Short- and long-term changes in plasma inflammatory markers associated with preeclampsia[J]. Hypertension, 2004, 44(5): 708–714. DOI:10.1161/01.HYP.0000143849.67254.ca.

共引文献192

同被引文献26

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部